1801 AUGUSTINE CUT-OFF, WILMINGTON, DE
Other Events
Financial Results, Press Release
Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio
Director Elections and Executive Compensation Approved at Annual Meeting
To Acquire Vega Therapeutics, a Wholly Owned Subsidiary, Expanding its Hematology Portfolio into Bleeding Disorders
Reports First Quarter 2026 Financial Results and Provides Business Updates
Annual Report to Security Holders
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Tender Offer Statement by Issuer
SC TO-I
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Tender Offer Statement by Issuer
Submission Upload
Correspondence